Literature DB >> 2309142

Molecular genetics of PKU in eastern Europe: a nonsense mutation associated with haplotype 4 of the phenylalanine hydroxylase gene.

T Wang1, Y Okano, R C Eisensmith, G Fekete, D Schuler, G Berencsi, I Nasz, S L Woo.   

Abstract

Phenylketonuria (PKU) is a genetic disorder secondary to a deficiency of hepatic phenylalanine hydroxylase (PAH). Several mutations in the PAH gene have recently been reported, and linkage disequilibrium was observed between RFLP haplotypes and specific mutations. A new molecular lesion has been identified in exon 7 of the PAH gene in a Hungarian PKU patient by direct sequencing of PCR-amplified DNA. The C-to-T transition causes the substitution of Arg243 to a termination codon, and the mutant allele is associated with haplotype 4 of the PAH gene. The mutation is present in two of nine mutant haplotype 4 alleles among Eastern Europeans and is not present among Western Europeans and Asians. The rarity of this mutant allele and its restricted geographic distribution suggest that the mutational event occurred recently on a normal haplotype 4 background in Eastern Europe.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2309142     DOI: 10.1007/bf01650483

Source DB:  PubMed          Journal:  Somat Cell Mol Genet        ISSN: 0740-7750


  14 in total

1.  Recurrent nonsense mutation in exon 7 of the phenylalanine hydroxylase gene.

Authors:  B Dworniczak; L Kalaydjieva; C Aulehla-Scholz; K Ullrich; I Kremensky; B Radeva; J Horst
Journal:  Hum Genet       Date:  1991-10       Impact factor: 4.132

Review 2.  The phenylketonuria locus: current knowledge about alleles and mutations of the phenylalanine hydroxylase gene in various populations.

Authors:  D S Konecki; U Lichter-Konecki
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

3.  A cytotoxic early gene of Bacillus subtilis bacteriophage SPO1.

Authors:  P Wei; C R Stewart
Journal:  J Bacteriol       Date:  1993-12       Impact factor: 3.490

4.  Founder effect of a prevalent phenylketonuria mutation in the Oriental population.

Authors:  T Wang; Y Okano; R C Eisensmith; M L Harvey; W H Lo; S Z Huang; Y T Zeng; L F Yuan; J I Furuyama; T Oura
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

5.  Comparison of genotype and intellectual phenotype in untreated PKU patients.

Authors:  S J Ramus; S M Forrest; D B Pitt; J A Saleeba; R G Cotton
Journal:  J Med Genet       Date:  1993-05       Impact factor: 6.318

6.  Phenylketonuria mutations and their relation to RFLP haplotypes at the PAH locus in Czech PKU families.

Authors:  L Kozák; V Kuhrová; M Blazková; V Romano; L Fajkusová; D Dvoráková; A Pijácková
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

Review 7.  Clinical application of genotypic diagnosis for phenylketonuria: theoretical considerations.

Authors:  F D Ledley
Journal:  Eur J Pediatr       Date:  1991-09       Impact factor: 3.183

8.  Genetic background of clinical homogeneity of phenylketonuria in Poland.

Authors:  J Jaruzelska; R Matuszak; S Lyonnet; F Rey; J Rey; J Filipowicz; K Borski; A Munnich
Journal:  J Med Genet       Date:  1993-03       Impact factor: 6.318

9.  A missense mutation, S349P, completely inactivates phenylalanine hydroxylase in north African Jews with phenylketonuria.

Authors:  M Weinstein; R C Eisensmith; V Abadie; S Avigad; S Lyonnet; G Schwartz; A Munnich; S L Woo; Y Shiloh
Journal:  Hum Genet       Date:  1993-02       Impact factor: 4.132

10.  Phenylketonuria genotypes correlated to metabolic phenotype groups in Norway.

Authors:  H G Eiken; P M Knappskog; K Motzfeldt; H Boman; J Apold
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.